Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color

Updated on: January 30,2024

Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

by Georgetown University Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center studied the microbiome of people with color

Updated on:January 30,2024

Scientists consider fighting potentially lethal form of breast cancer with chemical produced by the disease

by Delthia Ricks , Medical XpressSchematic model of GDP-M regulating HRD and immunity through promoting BRCA2 degradation. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitran

Updated on: March 30,2024

Scientists consider fighting potentially lethal form of breast cancer with chemical produced by the disease

by Delthia Ricks , Medical XpressSchematic model of GDP-M regulating HRD and immunity through promoting BRCA2 degradation. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitran

Updated on:March 30,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on: April 22,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on:April 22,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on: January 02,2024

Link between sphingolipids and complement signaling may be key to stopping cancer metastasis

by Caroline Wallace,Medical University of South CarolinaGraphical Abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111742MUSC Hollings Cancer Center researchers have i

Updated on:January 02,2024

Origins of glioma brain cancer found to be in the epigenome

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainWhile cancers often originate from mutations and other alterations of cells' DNA, researchers in the Bernstein Laboratory at D

Updated on: January 04,2024

Origins of glioma brain cancer found to be in the epigenome

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainWhile cancers often originate from mutations and other alterations of cells' DNA, researchers in the Bernstein Laboratory at D

Updated on:January 04,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on: January 13,2024

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on:January 13,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on: June 04,2024

Researchers find effective drug combinations for glioblastoma in mice

by The Spanish National Cancer Research CentreTelomeres (red) in mouse embryonic fibroblasts; DNA damage (green) caused by ERK inhibition. ERK is an enzyme in the RAS pathway whose inhibition lea

Updated on:June 04,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on: February 23,2024

Skin cancer-related mutations higher in the UK than Singapore, new study shows

by Wellcome Trust Sanger InstituteA representation of protein-altering mutations in 1 square centimeter of skin from donors of the UK and Singapore. The UK square contains many more circles. Cred

Updated on:February 23,2024

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi

Updated on: April 14,2024

Bolstering fat cells offers potential new leukemia treatment

by McMaster UniversityFat cells (white circles) in healthy human bone marrow, left, compared to bone marrow in a patient with leukemia, right. Credit: McMaster UniversityKilling cancer cells indi

Updated on:April 14,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on: January 12,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on:January 12,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on: June 15,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on:June 15,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024